Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Jodoigne – page 84

1 884 clinical trials in Jodoigne, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Jodoigne at a glance
1 884
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 884 trials in Jodoigne

Open in trial search

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Safety, Tolerability and Pharmacokinetics of Oral PF-07293893 in Healthy Adults for Future Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:PF-07293893
  • Sponsor:Pfizer Inc.

Relative Bioavailability of Sisunatovir Capsules vs Tablets in Fasted and Fed Conditions in Healthy Adults with Respiratory Syncytial Virus

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Sisunatovir
  • Sponsor:Pfizer Inc.

Colitis ulcerative+4

Not recruiting

Pharmacokinetic Study of Ritlecitinib Tosilate in Healthy Adults: Oral Solution, Short‑and Long‑Duration Capsules Fed vs Fasted – for ulcerative colitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Pfizer Inc.

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Narcolepsy

Not recruiting

Efficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ledasorexton
  • Sponsor:Eisai Limited

Overweight

Not recruiting

Study of PF-08653945 Bioavailability After Subcutaneous Injection in the Thigh, Upper Arm, or Abdomen in Adults with Obesity

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:PF-08653945
  • Sponsor:Pfizer Inc.

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Continuation study of JDQ443 in patients with KRAS G12C‑mutated non‑small cell lung cancer receiving JDQ443 as monotherapy or drug combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Batoprotafib
  • Sponsor:Novartis Pharma AG

Breast cancer+2

Not recruiting

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Celcuity Inc.

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Obesity

Not recruiting

Zenagamtide for Weight Loss in Adults with Obesity

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Jodoigne

What the registry says about research in the country

01 Gastroenterology Research

Innovative clinical investigations focusing on proton pump inhibitor (PPI) deprescribing strategies for patients with chronic usage patterns. This research examines alternative approaches for managing functional dyspepsia and related conditions.

  • PPI Usage Optimization
  • Gastrointestinal Health Management
  • Alternative Treatment Strategies

The study evaluates different therapeutic approaches, including on-demand medication use and alternative treatments, aiming to improve patient care in primary healthcare settings.

02 Primary Care Medicine

Comprehensive research examining optimal medication management strategies for patients with heartburn and reflux conditions. The study explores evidence-based approaches to reduce long-term medication dependence.

  • Medication Management
  • Patient-Centered Care
  • Treatment Optimization

This research initiative focuses on developing better strategies for long-term medication management while maintaining effective symptom control.

03 Clinical Therapeutics

Investigation into comparative effectiveness of various treatment strategies for gastroesophageal conditions. The research evaluates both traditional and innovative approaches to medication reduction.

  • Treatment Comparison Studies
  • Therapeutic Alternatives
  • Clinical Outcomes Assessment

The study aims to establish evidence-based guidelines for optimal therapeutic approaches in chronic medication management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.